These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30442225)

  • 61. Donor serum SMARCAL1 concentrations predict primary graft dysfunction in cardiac transplantation.
    Aharinejad S; Andrukhova O; Gmeiner M; Thomas A; Aliabadi A; Zuckermann A; Krenn K; Grimm M
    Circulation; 2009 Sep; 120(11 Suppl):S198-205. PubMed ID: 19752368
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transfusion increases the risk for vasoplegia after cardiac operations.
    Alfirevic A; Xu M; Johnston D; Figueroa P; Koch CG
    Ann Thorac Surg; 2011 Sep; 92(3):812-9. PubMed ID: 21788009
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Perioperative Management of the Cardiac Transplant Recipient.
    Rabin J; Kaczorowski DJ
    Crit Care Clin; 2019 Jan; 35(1):45-60. PubMed ID: 30447780
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vasoplegia in patients following ventricular assist device explant and heart transplantation.
    Emmanuel S; Pearman M; Jansz P; Hayward CS
    Perfusion; 2022 Mar; 37(2):152-161. PubMed ID: 33482711
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cardiac Power Output Index and Severe Primary Graft Dysfunction After Heart Transplantation.
    Lim HS; Ranasinghe A; Chue C; Quinn D; Mukadam M; Mascaro J
    J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):398-403. PubMed ID: 32747204
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interleukin-17 receptor polymorphism predisposes to primary graft dysfunction after lung transplantation.
    Somers J; Ruttens D; Verleden SE; Vandermeulen E; Piloni D; Wauters E; Lambrechts D; Vos R; Verleden GM; Vanaudenaerde B; van Raemdonck DE
    J Heart Lung Transplant; 2015 Jul; 34(7):941-9. PubMed ID: 25935436
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Risk factors for early primary graft dysfunction after lung transplantation: a registry study.
    Kuntz CL; Hadjiliadis D; Ahya VN; Kotloff RM; Pochettino A; Lewis J; Christie JD
    Clin Transplant; 2009; 23(6):819-30. PubMed ID: 19239481
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prothrombin Complex Concentrate and Methylene Blue for Treatment of Coagulopathy and Vasoplegia in a Pediatric Heart Transplant Patient.
    Lee JK; Ing C
    A A Case Rep; 2016 Mar; 6(5):127-9. PubMed ID: 26599739
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk factors for post-transplant low output syndrome.
    Fujita T; Toda K; Yanase M; Seguchi O; Murata Y; Ishibashi-Ueda H; Kobayashi J; Nakatani T
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):551-6. PubMed ID: 22328624
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting.
    Sovic W; Mathew C; Blough B; Monday KA; Sam T; Zafar H; Guerrero-Miranda C; Sherwood M; Hebert C; Hall S; Alam A
    Methodist Debakey Cardiovasc J; 2021; 17(4):98-101. PubMed ID: 34824689
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preoperative Statin Therapy and Heart Transplantation Outcomes.
    Peled Y; Klempfner R; Kassif Y; Kogan A; Maor E; Sternik L; Lavee J; Ram E
    Ann Thorac Surg; 2020 Oct; 110(4):1280-1285. PubMed ID: 32156588
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic Value of the Nutritional Risk Index in Heart Transplant Recipients.
    Barge-Caballero E; García-López F; Marzoa-Rivas R; Barge-Caballero G; Couto-Mallón D; Paniagua-Martín MJ; Solla-Buceta M; Velasco-Sierra C; Pita-Gutiérrez F; Herrera-Noreña JM; Cuenca-Castillo JJ; Vázquez-Rodríguez JM; Crespo-Leiro MG
    Rev Esp Cardiol (Engl Ed); 2017 Aug; 70(8):639-645. PubMed ID: 28209304
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Primary Graft Dysfunction in Heart Transplant Recipients-Risk Factors and Longitudinal Outcomes.
    Smith NF; Salehi Omran S; Genuardi MV; Horn ET; Kilic A; Sciortino CM; Keebler ME; Kormos RL; Hickey GW
    ASAIO J; 2022 Mar; 68(3):394-401. PubMed ID: 34593684
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Perioperative factors associated with in-hospital mortality or retransplantation in pediatric heart transplant recipients.
    Vanderlaan RD; Manlhiot C; Conway J; Honjo O; McCrindle BW; Dipchand AI
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):282-9. PubMed ID: 24755331
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Methylene blue is associated with poor outcomes in vasoplegic shock.
    Weiner MM; Lin HM; Danforth D; Rao S; Hosseinian L; Fischer GW
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1233-8. PubMed ID: 23972738
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Kidney transplantation on extracorporeal life support for primary cardiac allograft dysfunction.
    Pham AN; Patel PC; Landolfo K; Burns JM; Yip DS; Leoni Moreno JC; Goswami RM; Jacob S; El-Sayed Ahmed MM; Makey IA; Thomas M; Mai ML; Taner CB; Pham SM
    J Card Surg; 2020 Mar; 35(3):725-728. PubMed ID: 32017259
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Elevated Cardiac Troponin I in Preservation Solution Is Associated With Primary Graft Dysfunction.
    Schechter MA; Watson MJ; Feger BJ; Southerland KW; Mishra R; Dibernardo LR; Kuchibhatla M; Schroder JN; Daneshmand MA; Patel CB; Rogers JG; Milano CA; Bowles DE
    J Card Fail; 2016 Feb; 22(2):158-62. PubMed ID: 26365053
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Temporary Venoarterial Extracorporeal Membrane Oxygenation: Ten-Year Experience at a Cardiac Transplant Center.
    Tran BG; De La Cruz K; Grant S; Meltzer J; Benharash P; Dave R; Ardehali A; Shemin R; Depasquale E; Nsair A
    J Intensive Care Med; 2018 May; 33(5):288-295. PubMed ID: 27302906
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Circulating Cell Death Biomarkers May Predict Survival in Human Lung Transplantation.
    Hashimoto K; Besla R; Zamel R; Juvet S; Kim H; Azad S; Waddell TK; Cypel M; Liu M; Keshavjee S
    Am J Respir Crit Care Med; 2016 Jul; 194(1):97-105. PubMed ID: 26796350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.